Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS.
Ernesto ManzoIleana LorenziniDianne BarramedaAbigail G O'ConnerJordan M BarrowsAlexander StarrTina KovalikBenjamin E RabichowErik M LehmkuhlDakotah D ShreinerArchi JoardarJean-Charles LiévensRobert BowserRita SattlerDaniela C ZarnescuPublished in: eLife (2019)
Amyotrophic Lateral Sclerosis (ALS), is a fatal neurodegenerative disorder, with TDP-43 inclusions as a major pathological hallmark. Using a Drosophila model of TDP-43 proteinopathy we found significant alterations in glucose metabolism including increased pyruvate, suggesting that modulating glycolysis may be neuroprotective. Indeed, a high sugar diet improves locomotor and lifespan defects caused by TDP-43 proteinopathy in motor neurons or glia, but not muscle, suggesting that metabolic dysregulation occurs in the nervous system. Overexpressing human glucose transporter GLUT-3 in motor neurons mitigates TDP-43 dependent defects in synaptic vesicle recycling and improves locomotion. Furthermore, PFK mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology. Surprisingly, PFK overexpression rescues TDP-43 induced locomotor deficits. These findings from multiple ALS models show that mechanistically, glycolysis is upregulated in degenerating motor neurons as a compensatory mechanism and suggest that increased glucose availability is protective.
Keyphrases
- amyotrophic lateral sclerosis
- spinal cord
- spinal cord injury
- endothelial cells
- cell proliferation
- signaling pathway
- induced pluripotent stem cells
- traumatic brain injury
- type diabetes
- cerebral ischemia
- blood pressure
- oxidative stress
- mouse model
- radiation therapy
- high glucose
- poor prognosis
- weight loss
- insulin resistance
- adipose tissue
- brain injury
- subarachnoid hemorrhage
- binding protein
- stress induced
- prefrontal cortex